Hoag Memorial Hospital Presbyterian

Newport Beach, CA

Sorting 2 by

Accepting patients

CD38-Targeted ImmunoPET

A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma
  • Monoclonal Antibody
  • CD38
  • Phase 2

Not yet accepting

QXL138AM

A First-in-human Phase 1a/1b Study to Evaluate Safety and Tolerability of QXL138AM in Patients With Locally Advanced Un-resectable and/or Metastatic Solid Tumors and Multiple Myeloma
  • Masked Immunocytokine (MIC)
  • CD138
  • Phase 1